Verition Fund Management’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-67,304
| Closed | -$225K | – | 2640 |
|
|
2024
Q4 | $225K | Buy |
67,304
+10,395
| +18% | +$34.8K | ﹤0.01% | 2274 |
|
|
2024
Q3 | $191K | Sell |
56,909
-9,067
| -14% | -$30.4K | ﹤0.01% | 2204 |
|
|
2024
Q2 | $218K | Buy |
+65,976
| New | +$218K | ﹤0.01% | 1902 |
|
|
2023
Q4 | – | Sell |
-22,954
| Closed | -$68.9K | – | 1892 |
|
|
2023
Q3 | $68.9K | Buy |
+22,954
| New | +$68.9K | ﹤0.01% | 1798 |
|
|
2021
Q3 | – | Sell |
-14,375
| Closed | -$309K | – | 1637 |
|
|
2021
Q2 | $309K | Buy |
+14,375
| New | +$309K | ﹤0.01% | 1203 |
|